Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6401)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2013 (publication date) through Jan 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 2013; 19(45): 8357-8365 [PMID: 24363528 DOI: 10.3748/wjg.v19.i45.8357] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8357.htm |
| Number | Citing Articles |
| 1 |
Massimo Imbriaco, Serena De Luca, Milena Coppola, Mario Fusari, Michele Klain, Marta Puglia, Pierpaolo Mainenti, Raffaele Liuzzi, Simone Maurea. Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT). Polish Journal of Radiology 2018; 82: 50 doi: 10.12659/PJR.899239
|
| 2 |
Dorota Rybczynska, Karolina Markiet, Joanna Pienkowska, Andrzej Frydrychowski. Is there added value of the hepatobiliary phase of MRI with hepatobiliary contrast agents for hepatocellular carcinoma diagnosis? A meta-analysis. Polish Journal of Radiology 2024; 89: 402 doi: 10.5114/pjr/189614
|
| 3 |
Hersh Chandarana, Li Feng, Justin Ream, Annie Wang, James S. Babb, Kai Tobias Block, Daniel K. Sodickson, Ricardo Otazo. Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. Investigative Radiology 2015; 50(11): 749 doi: 10.1097/RLI.0000000000000179
|
| 4 |
Si Eun Lee, Chansik An, Shin Hye Hwang, Jin-Young Choi, Kyunghwa Han, Myeong-Jin Kim. Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease. European Radiology 2018; 28(4): 1551 doi: 10.1007/s00330-017-5119-y
|
| 5 |
Yuying Chen, Jia Chen, Yu Zhang, Zhi Lin, Meng Wang, Lifei Huang, Mengqi Huang, Mimi Tang, Xiaoqi Zhou, Zhenpeng Peng, Bingsheng Huang, Shi-Ting Feng. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging. Journal of Hepatocellular Carcinoma 2021; : 795 doi: 10.2147/JHC.S313879
|
| 6 |
Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana Alcantara Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei-Jer Chen, Cosmas Rinaldi A. Lesmana, Laurentius A. Lesmana, Rino A. Gani, Shuntaro Obi, A. Kadir Dokmeci, Shiv Kumar Sarin. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology International 2017; 11(4): 317 doi: 10.1007/s12072-017-9799-9
|
| 7 |
Kelvin Cortis, Rosa Liotta, Roberto Miraglia, Settimo Caruso, Fabio Tuzzolino, Angelo Luca. Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity. Acta Radiologica 2016; 57(8): 923 doi: 10.1177/0284185115616291
|
| 8 |
Huilin Chen, Hui Dong, Ruilin He, Mengting Gu, Xingyu Zhao, Kairong Song, Wenjie Zou, Ningyang Jia, Wanmin Liu. Optimizing predictions: improved performance of preoperative gadobenate-enhanced MRI hepatobiliary phase features in predicting vessels encapsulating tumor clusters in hepatocellular carcinoma—a multicenter study. Abdominal Radiology 2024; 49(10): 3412 doi: 10.1007/s00261-024-04283-y
|
| 9 |
Tin Nadarevic, Agostino Colli, Vanja Giljaca, Mirella Fraquelli, Giovanni Casazza, Cristina Manzotti, Davor Štimac, Damir Miletic. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD014798.pub2
|
| 10 |
E. Neri, M. A. Bali, A. Ba-Ssalamah, P. Boraschi, G. Brancatelli, F. Caseiro Alves, L. Grazioli, T. Helmberger, J. M. Lee, R. Manfredi, L. Martì-Bonmatì, C. Matos, E. M. Merkle, B. Op De Beeck, W. Schima, S. Skehan, V. Vilgrain, C. Zech, C. Bartolozzi. ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. European Radiology 2016; 26(4): 921 doi: 10.1007/s00330-015-3900-3
|
| 11 |
Nir Lubezky, Yaacov Goykhman, Richard Nakache, Ido Nachmany. Hepatocellular Carcinoma. 2016; : 467 doi: 10.1007/978-3-319-34214-6_31
|
| 12 |
Su Jong Yu, Jeong-Ju Yoo, Dong Ho Lee, Su Jin Kim, Eun Ju Cho, Se Hyung Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jeong Min Lee, Jae Young Lee, Jung-Hwan Yoon. Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis. Biomedicines 2023; 11(2): 382 doi: 10.3390/biomedicines11020382
|
| 13 |
Joanna K. Duncan, Ning Ma, Thomas D. Vreugdenburg, Alun L. Cameron, Guy Maddern. Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Magnetic Resonance Imaging 2017; 45(1): 281 doi: 10.1002/jmri.25345
|
| 14 |
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai. Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update. Oncology 2014; 87(Suppl. 1): 7 doi: 10.1159/000368141
|
| 15 |
Grzegorz Rosiak, Joanna Podgorska, Edyta Rosiak, Andrzej Cieszanowski. Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7465126
|
| 16 |
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 2018; 69(1): 182 doi: 10.1016/j.jhep.2018.03.019
|
| 17 |
M. Plaikner, C. Kremser, H. Zoller, M. Steurer, B. Glodny, W. Jaschke, B. Henninger. Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?. European Radiology 2019; 29(2): 829 doi: 10.1007/s00330-018-5616-7
|
| 18 |
Jielin Pan, Wenjuan Li, Lingjing Gu, Chaoran Liu, Ke Zhang, Guobin Hong. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis. European Radiology 2022; 32(11): 7883 doi: 10.1007/s00330-022-08826-z
|
| 19 |
Arvin Arian, Ayoob Dinar Abdullah, Hayder J Taher, Hayder Suhail Alareer, Maryam Fotouhi . Diagnostic Values of the Liver Imaging Reporting and Data System in the Detection and Characterization of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.36082
|
| 20 |
Wang Yinzhong, Tian Xiaoxue, Tian Jinhui, Yang Pengcheng, Liu Xiaoying, Lei Junqiang. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance
Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma?
A Systematic Review with Meta-Analysis. Current Medical Imaging Formerly Current Medical Imaging Reviews 2022; 18(6): 633 doi: 10.2174/1573405617666210917124404
|
| 21 |
Aditya Kale. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99839
|
| 22 |
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai, Takuji Okusaka, Shiro Miyayama, Kaoru Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka, Masafumi Ikeda, Sadahisa Ogasawara, Tatsuya Yamashita, Tetsuya Minami, Koichiro Yamakado. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer 2014; 3(3-4): 458 doi: 10.1159/000343875
|